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Abstract 
Background: Rapid diagnostic tests (RDT) and real-time PCR (qPCR) assays are sensitive for diagnosing malaria, but 
because they detect antigen and DNA, respectively, positivity may not reflect active infection. Performance character-
istics of RDT and qPCR in Plasmodium falciparum positive specimens were evaluated over time to elucidate duration 
of positivity following conversion to microscopy negative.
Methods: Specimens from patients with at least one specimen that was positive for P. falciparum by microscopy, and 
at least one specimen that was negative for P. falciparum within a 1-month period were identified. Survival distribu-
tions of the diagnostic tests over time were compared. Performance characteristics for each test were calculated.
Results: Ninety specimens were included, with 48 initially positive for P. falciparum, and 42 subsequently negative. 
Of 42 specimens that converted to microscopy-negative following an initial positive, 26 (61.9 %) and 41 (97.6 %) were 
positive by qPCR and RDT, respectively. Survival curves of microscopy versus qPCR, as well as microscopy vs RDT dif-
fered significantly (p = 0.0002 and p < 0.0001, respectively). Compared to microscopy, sensitivity of qPCR was 100.0 % 
(95 % CI 90.8–100.0 %), and that of RDT was 100.0 % (95 % CI 90.8–100.0 %).
Conclusions: Due to slow clearance of circulating antigen and DNA from bloodstream, RDT and qPCR have low 
positive predictive value for clinically relevant asexual parasitaemia in post-treatment specimens. Thus, microscopy 
remains the only available malaria diagnostic that can reliably distinguish true asexual parasitaemia from prolonged 
clearance of antigen and nucleic acid in a convalescing patient.
Keywords: Plasmodium falciparum, Malaria diagnosis, PCR, Rapid antigen detection test
© 2015 Phuong et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Three common methods are used to diagnose malaria: 
microscopic examination of Giemsa-stained thick and 
thin blood smears; rapid diagnostic tests (RDTs); and 
polymerase chain reaction (PCR) or other nucleic-acid 
based assays [1, 2]. These tests have varying degrees of 
sensitivity and specificity for different Plasmodium spe-
cies [2, 3], however, they are highly sensitive for detecting 
Plasmodium falciparum, as species-specific morphology, 
histidine-rich protein 2 (HRP-2), and species-specific 18S 
rRNA gene can all be detected or amplified [1, 4].
Microscopy remains the gold standard diagnostic test 
for malaria due to its sensitivity and specificity in expert 
microscopist hands, although considerable expertise is 
required, and results are operator dependent [2, 4]. RDTs 
are routinely implemented due to their relative simplic-
ity and rapid turnaround time, enabling them to function 
as a point-of-care diagnostic. The specificity of RDTs can 
be low, particularly in the setting of persistent antigenae-
mia post-treatment of P. falciparum infection, as well as 
non-falciparum species [2, 5–7]. More recently, real-time 
polymerase chain reaction (qPCR) has become increas-
ingly implemented, although its availability is limited 
to well-resourced reference facilities. qPCR assays have 
high sensitivity and specificity, and they may be used to 
confirm ambiguous microscopic results as well as iden-
tify the presence of mixed infections [1]. Given that RDTs 
and qPCR detect parasite antigen and DNA, respectively, 
Open Access
*Correspondence:  andrea.boggild@utoronto.ca 
3 Tropical Disease Unit, Division of Infectious Diseases, UHN-Toronto 
General Hospital, 200 Elizabeth Street, 13EN-218, Toronto, ON M5G 2C4, 
Canada
Full list of author information is available at the end of the article
Page 2 of 6Phuong et al. Malar J  (2015) 14:350 
specificity can be compromised if clearance of these par-
asite components from the bloodstream of the patient is 
slow [5, 7].
The aim of this study was to examine the length of time 
that qPCR and RDT results remain positive in speci-
mens from patients recovering from recent P. falciparum 
infection. The natural history of HRP-2 and 18S DNA 
clearance relative to microscopy is herein described in 




Surplus and anonymized malaria-positive specimens 
entered into the malaria biobank were identified and 
included in the analysis if: multiple specimens from a sin-
gle individual were entered with not more than 1-month 
between the first and second specimen; isolated P. falci-
parum malaria was confirmed microscopically for the 
first specimen, with conversion to microscopic negativ-
ity or declining parasitaemia on at least one subsequent 
specimen; complete RDT (BinaxNOW Malaria kit, Alere, 
ME) and Giemsa-stained thick and thin film microscopy 
results within the biobank database; and submission to 
the laboratory between October 2008 and April 2014.
DNA extraction
DNA was extracted from banked whole blood specimens 
using DNA Mini Kit Blood or Body Fluid Spin Protocol 
(Qiagen, Germantown, MD, USA). For each specimen, 
200 μL of frozen whole blood was thawed from −80 °C 
and DNA was eluted with 60  μL AE buffer. DNA was 
then stored at −20 °C prior to amplification.
Qualitative real‑time PCR
All specimens underwent the following qPCR assays: 
human beta-2-microglobulin (B2MG) extraction con-
trol, Plasmodium malariae/Plasmodium ovale species-
specific duplex and P. falciparum/Plasmodium vivax 
species-specific duplex, as previously described [8]. 
Plasmodium falciparum/P. vivax species-specific duplex 
qPCR assay was conducted to confirm the isolated pres-
ence of P. falciparum and quantify copy number of the 
18S rRNA gene. Plasmodium malariae/P. ovale species-
specific duplex qPCR was conducted to exclude initial 
mixed infection as well. All qPCR assays were run using 
ABI 7900HT Real-time PCR System using the following 
standard conditions: 50  °C for 2  min, 95  °C for 10  min, 
95 °C for 15 s, and 60 °C for 1 min (45 cycles), as previ-
ously described [8]. For each 25-µL reaction, 12.5 µL of 
TaqMan universal PCR master mix (Life Technologies), 
7.5  µL of primer and probe mixes with concentrations 
previously reported [1, 2, 8] and 5 µL of DNA were used.
All qPCR amplification curves were analysed using a 
manual Ct threshold of 0.02 and an automatic baseline. 
Positive results were identified if the Ct value was <40 
for the B2MG and P. falciparum/P. vivax species-specific 
duplex assays or <38 for the P. malariae/P. ovale species-
specific duplex assay, as previously described [8].
Quantitative real‑time PCR
In order to quantify gene copy number, serial dilutions of 
a P. falciparum 18S rRNA DNA clone (MRA-177 ATCC® 
83, Virginia) that ranged from 9 to 91 million copies/
qPCR reaction were prepared and were included in each 
run of the P. falciparum/P. vivax species-specific duplex 
qPCR assay. The logarithm of gene copy number was 
plotted against Ct values for each concentration of the 
clone. A linear regression was conducted from this graph, 
and the equation was used to calculate gene copy number 
for each banked specimen.
Statistical analysis
The number of days between each specimen in a group 
of specimens for a single case were calculated. Kaplan–
Meier survival curves were constructed, where an event 
was defined as either negative microscopy, qPCR, or 
RDT result. The alpha level (α) was predetermined to be 
0.05 for the log-rank test of all three diagnostic proce-
dures, and a Bonferroni correction was applied for post 
hoc analysis among the three diagnostic tests.
To evaluate test performance characteristics for sub-
sequent samples received after the initial specimen, two 
sets of calculations were conducted: one using micros-
copy as the reference standard, and one using qPCR as 
the reference standard. For each scenario, sensitivity, 
specificity, positive predictive value (PPV), and negative 
predictive value (NPV) were calculated. Analysis was 
conducted using IBM SPSS Statistics (IBM, New York, 
USA) and graphs were prepared using GraphPad Prism 5 
(GraphPad Software, La Jolla, CA, USA).
Results
In total, 90 specimens from 24 individuals entered into 
the malaria biobank were analysed.
Microscopy, rapid diagnostic test, and real‑time PCR 
comparison
Twenty-four initial specimens and 66 subsequent speci-
mens were received from 24 patients, where 48 initial 
specimens were positive for P. falciparum by microscopy, 
with 42 subsequently collected specimens converting to 
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microscopy negative. Out of 90 specimens, 89 (98.9  %) 
were positive for HRP-2 by RDT, thus, 41 microscopy-
negative specimens (97.6 %) were positive by RDT. Sev-
enty-four specimens (82.2  %) were positive by qPCR, 
thus 26 microscopy negative specimens (61.9  %) were 
positive by qPCR.
Time between the last P. falciparum-positive micro-
scopic result, positive qPCR, and RDT is summarized 
in Fig. 1. qPCR and RDT remained positive up to 19 and 
63  days following microscopic conversion to negativity, 
respectively. In two cases, multiple specimens submitted 
over a period of 2 months, and time between the last P. 
falciparum-positive microscopic result, positive qPCR, 
and RDT for these two cases with multiple specimens is 
summarized in Fig. 2.
The three survival distributions (Fig. 3) were found to 
be significantly different by log-rank test [χ2(2) = 39.62, 
p < 0.0001]. Specifically, survival distributions of micros-
copy and qPCR, as well as microscopy and RDT were 
found to differ significantly [χ2(1)  =  14.11, p  =  0.0002 
and χ2(1) = 31.79, p < 0.0001, respectively].
Performance characteristics of qPCR and RDT com-
pared to microscopy for samples received after the ini-
tial specimen are summarized in Table 1. Sensitivity and 
specificity of qPCR were 100.0 % (95 % CI 82.8–100.0 %), 
and 38.1 % (95 % CI 24.0–54.3 %), respectively. PPV for 
qPCR was 48.0  % (95  % CI 33.9–62.4  %) and NPV was 
100.0  % (95  % CI 75.9–100.0  %). Compared to micros-
copy, sensitivity of RDT for asexual parasitaemia was 
100.0 % (95 % CI 82.8–100.0 %) and specificity was 2.4 % 
(95 % CI 0.1–14.1 %). PPV and NPV for RDT were 36.9 % 
(95 % CI 25.6–49.8 %) and 100.0 % (95 % CI 5.5–100.0 %) 
compared to microscopy, respectively.
Performance characteristics of microscopy and RDT 
compared to qPCR are summarized in Table 2. Sensitiv-
ity and specificity of microscopy were 75.8  % (95  % CI 
63.4–85.1 %) and 100.0 % (95 % CI 75.9–100.0 %), com-
pared to qPCR, respectively. PPV was 100.0  % (95  % 
CI 82.8–100.0  %) and NPV was 38.1  % (95  % CI 24.0–
54.3  %). Compared to qPCR, sensitivity of RDT was 
100.0 % (95 % CI 91.1–100.0 %) and specificity was 6.3 % 
(95 % CI 0.3–32.3 %). PPV and NPV for RDT were 98.5 % 
Positive
Negative
Fig. 1 Number of days between the time from last P. falciparum-positive specimen by microscopy was collected and the time when subsequent 
specimens which were microscopically negative but positive by either qPCR or BinaxNOW were collected for each case. Copy number from each 
specimen in each reaction was plotted for qPCR. For RDT, 1.0 indicates a positive result, whereas −1.0 indicates a negative result
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(95 % CI 64.5–86.1 %) and 100.0 % (95 % CI 5.5–100.0 %) 
compared to qPCR, respectively. RDT had a very low 
specificity and PPV for asexual P. falciparum parasitae-
mia, regardless of comparator.
Discussion
Of three main diagnostic platforms—microscopy, PCR, 
and RDT—microscopy is considered the gold standard 
[9, 10]. Furthermore, microscopy is the only available 
diagnostic test for malaria that can reliably differenti-
ate sexual from asexual parasitaemia. As PCR and RDT 
detect parasite components rather than the whole para-
site itself, clearance from the bloodstream may be delayed 
[2, 7], and may yield false-positive results post-treatment. 
In addition, sexual stages of P. falciparum (gametocytes), 
which have no clinical relevance, may lead to positive 
RDT and/or qPCR, and this may be misinterpreted by 
clinicians as relapse or recrudescence of asexual parasi-
taemia. Recommendations to perform day-7 and day-
28 follow-up parasitaemia levels in falciparum malaria 
[11], were made prior to the widespread use of RDTs and 
qPCR assays in hematology and reference laboratories, 
and must be interpreted accordingly. Understanding the 
performance limitations of RDT and qPCR is imperative 
to correct interpretation of malaria diagnostic tests in 
clinical cases of malaria, particularly following appropri-
ate administration of therapeutic anti-malarials. As labo-
ratories are often not privy to ongoing clinical details in 
falciparum malaria, careful reporting of RDT and qPCR 
results must be undertaken, with sufficient exposition 
of limitations, particularly in the context of microscopic 
conversion to negativity.
Through survival analysis, we have documented the 
significant time difference in clearance of whole parasites, 
DNA, and HRP-2 following initial reporting of P. falcipa-
rum asexual parasitaemia. This study is limited in its abil-
ity to provide a robust estimate of clearance time for each 
test due to the small number of enrolled specimens and 
collection at different time points following the initial 
positive test. Furthermore, there is the potential for bias 
in the studied sample, as uncomplicated cases or patients 
who are semi-immune may be less likely to return for fol-
low-up testing. Thus, more rapid parasite DNA or HRP-2 
clearance may by under-represented in this study. Future 
studies with prospective enrolment of patients and daily 
follow-up of microscopic parasitaemia, RDT, and qPCR 
would address this limitation and provide a more precise 
estimate of clearance for each test.
Conclusions
Microscopy, qPCR, and RDT have variable performance 
characteristics and taken together, provide highly sen-
sitive and specific detection of P. falciparum asexual 
parasitaemia. For follow-up post-treatment, how-
ever, microscopy still remains the only assay with ade-
quate specificity for ongoing asexual parasitaemia and 
Positive 
Negative 
Fig. 2 Positivity of qPCR and RDT results following initial confirmation of P. falciparum-negative conversion by microscopy in two sets of specimens 
with frequent samples submitted over a 1-month period
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with low relative risk of false positivity. Laboratories 
must be cognizant of the RDT and qPCR performance 
limitations that, if reported in isolation, may lead to 
misinterpretation of results and potential erroneous re-
treatment of malaria in a clinically-well patient free of 
asexual parasitaemia.
Fig. 3 Kaplan–Meier survival curves for all three diagnostic assays
Table 1 Performance characteristics of qPCR and BinaxNOW 











qPCR 24 16 26 0
BinaxNOW 24 1 41 0
Table 2 Performance characteristics of  microscopy and   











Microscopy 24 16 0 26
BinaxNOW 50 1 15 0
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